Substrate specificity of the Trypanosoma cruzi trans-sialidase. 1992

F Vandekerckhove, and S Schenkman, and L Pontes de Carvalho, and S Tomlinson, and M Kiso, and M Yoshida, and A Hasegawa, and V Nussenzweig
Michael Heidelberger Division of Immunology, Department of Pathology (MSB 130), New York University Medical Center, NY 10016.

Trypanosoma cruzi trypomastigotes acquire sialic acid (SA) from host glycoconjugates by means of a plasma membrane-associated trans-sialidase (TS). Here we study the substrate specificity of TS, which differs from all known sialyltransferases in that it does not require cytidine monophosphate (CMP)-SA as donor. The T. cruzi TS reversibly transfers SA to saccharides with terminal beta-Gal (but not alpha-Gal) residues. Donors are saccharides with SA linked to terminal beta-Gal residues by (alpha 2-3), but not (alpha 2-6) bonds. The type of beta-linkage of the terminal Gal residue is of minor importance (beta 1-4 and beta 1-6 are slightly better than beta 1-3), whereas chain length and the structure of additional vicinal sugar residues are not relevant. SA on the surface of living trypomastigotes of T. cruzi is transferred back and forth between the parasite surface and acceptor molecules with terminal beta-Gal, either in solution or on the surface of neighbouring mammalian cells. Addition of fucose residue on or close to the terminal galactose impairs TS activity. As a consequence, the enzyme acts poorly on the E-selectin ligand sialyl-Lewisx and its precursor Lewisx, and in vitro adhesion of TS-treated neutrophils to L-cells expressing L-selectin is not affected. Modifications in the structure of the (alpha 2-3)-linked N-acetyl-neuraminic acid (Neu5Ac) (deoxy or methoxy) of the donor molecules do not impair transfer if the changes are at C9, whereas changes at C4, C7 and C8 impair the ability to donate the modified SA.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007983 Lewis Blood Group Antigens Carbohydrate antigens structurally related to the ABH BLOOD-GROUP SYSTEM. They may occur as a modification of saccharide chains on glycolipids or glycoproteins on cell surfaces or in plasma, or as free oligosaccharides in secretions. Lewis antigens are not synthesized in blood cells. Instead Lewis glycolipids present in plasma are absorbed onto the surface of ERYTHROCYTES; LYMPHOCYTES; and PLATELETS. The phenotypes Le(a) and Le(b) are the result of the actions of two genes the Le gene (fucosyltransferase FUT3) and the Se gene (fucosyltransferase FUT2) on the precursor carbohydrate, glycolipid or glycoprotein. Other FUCOSYLTRANSFERASES can also synthesize the Lewis antigens. Blood Group Lewis Related Antigens,Lewis Antigen Related Tumor-Associated Antigens,Lewis Antigens,Lewis Blood Group Related Antigens,Lewis Blood Group Related Tumor-Associated Antigens,Lewis Blood-Group System,Lewis Related Antigens,Lewis System,Sialyl Lewis Antigens,Le Antigens,Le(a) Blood Group System,Antigens, Lewis,Antigens, Lewis Related,Antigens, Sialyl Lewis,Blood-Group System, Lewis,Lewis Antigen Related Tumor Associated Antigens,Lewis Blood Group Related Tumor Associated Antigens,Lewis Blood Group System
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009005 Monosaccharides Single chain carbohydrates that are the most basic units of CARBOHYDRATES. They are typically colorless crystalline substances with a sweet taste and have the same general formula CnH2nOn. Monosaccharide,Simple Sugar,Simple Sugars,Sugar, Simple,Sugars, Simple
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D009844 Oligosaccharides Carbohydrates consisting of between two (DISACCHARIDES) and ten MONOSACCHARIDES connected by either an alpha- or beta-glycosidic link. They are found throughout nature in both the free and bound form. Oligosaccharide
D002236 Carbohydrate Conformation The characteristic 3-dimensional shape of a carbohydrate. Carbohydrate Linkage,Carbohydrate Conformations,Carbohydrate Linkages,Conformation, Carbohydrate,Conformations, Carbohydrate,Linkage, Carbohydrate,Linkages, Carbohydrate
D002240 Carbohydrate Sequence The sequence of carbohydrates within POLYSACCHARIDES; GLYCOPROTEINS; and GLYCOLIPIDS. Carbohydrate Sequences,Sequence, Carbohydrate,Sequences, Carbohydrate
D004187 Disaccharides Oligosaccharides containing two monosaccharide units linked by a glycosidic bond. Disaccharide
D005643 Fucose A six-member ring deoxysugar with the chemical formula C6H12O5. It lacks a hydroxyl group on the carbon at position 6 of the molecule. Deoxygalactose,alpha-Fucose,alpha Fucose
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated

Related Publications

F Vandekerckhove, and S Schenkman, and L Pontes de Carvalho, and S Tomlinson, and M Kiso, and M Yoshida, and A Hasegawa, and V Nussenzweig
August 1999, Biochemical Society transactions,
F Vandekerckhove, and S Schenkman, and L Pontes de Carvalho, and S Tomlinson, and M Kiso, and M Yoshida, and A Hasegawa, and V Nussenzweig
January 1993, Annual review of microbiology,
F Vandekerckhove, and S Schenkman, and L Pontes de Carvalho, and S Tomlinson, and M Kiso, and M Yoshida, and A Hasegawa, and V Nussenzweig
October 2004, Glycobiology,
F Vandekerckhove, and S Schenkman, and L Pontes de Carvalho, and S Tomlinson, and M Kiso, and M Yoshida, and A Hasegawa, and V Nussenzweig
June 1993, Parasitology today (Personal ed.),
F Vandekerckhove, and S Schenkman, and L Pontes de Carvalho, and S Tomlinson, and M Kiso, and M Yoshida, and A Hasegawa, and V Nussenzweig
May 1996, Molecular and biochemical parasitology,
F Vandekerckhove, and S Schenkman, and L Pontes de Carvalho, and S Tomlinson, and M Kiso, and M Yoshida, and A Hasegawa, and V Nussenzweig
February 2010, Bioorganic & medicinal chemistry,
F Vandekerckhove, and S Schenkman, and L Pontes de Carvalho, and S Tomlinson, and M Kiso, and M Yoshida, and A Hasegawa, and V Nussenzweig
September 2007, Carbohydrate research,
F Vandekerckhove, and S Schenkman, and L Pontes de Carvalho, and S Tomlinson, and M Kiso, and M Yoshida, and A Hasegawa, and V Nussenzweig
May 2013, Biochemistry,
F Vandekerckhove, and S Schenkman, and L Pontes de Carvalho, and S Tomlinson, and M Kiso, and M Yoshida, and A Hasegawa, and V Nussenzweig
January 1995, Parasitology research,
F Vandekerckhove, and S Schenkman, and L Pontes de Carvalho, and S Tomlinson, and M Kiso, and M Yoshida, and A Hasegawa, and V Nussenzweig
July 2017, Journal of drug targeting,
Copied contents to your clipboard!